Sam Ricchezza retweeted
News - Press Releases and Announcements - Detail - Rentschler Biopharma rentschler-biopharma.com/new…
Sam Ricchezza retweeted
Here's some coverage from the @AllogeneTx deal with new Canadian startup Notch Therapeutics, founded by @PZandstra and Juan Carlos Zúñiga-Pflücker bit.ly/2JWFPkh. Big congratulations again to everyone involved! #TMM2019
Sam Ricchezza retweeted
We Are Now Offering Three Grades of pDNA Vectors to Our Clients! Need pDNA vectors for your project? Is your project for pre-clinical, clinical or commercial? We’ve got you covered. hubs.ly/H0lsM4T0 or contact us at [email protected]
#pDNA #genetherapy #plasmidDNA
Sam Ricchezza retweeted
First-Ever OTC Inspections Drove Surge Of FDA Warning Letters In FY 2019 :: Pink Sheet pink.pharmaintelligence.info…
Sam Ricchezza retweeted
New @PBOAssoc e-newsletter, w/@PiramalPharma @CatalentPharma @ThermoFisherPR @LZLifeSciHealth @masybioservices @CobraBiologics @idtbiologika @samsungbiologi @RecipharmAB & more! Read/subscribe:
mailchi.mp/pharma-bio/pirama…
Sam Ricchezza retweeted
Member news: @CBiologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture globenewswire.com/news-relea…
Sam Ricchezza retweeted
1/2 Congress is considering questions of Rx manufacturing, so let's get all our facts straight. According to @US_FDA data: 𝟔𝟎% of generic medicine doses come from outside the U.S., but only 𝟖.𝟓% from China and only 𝟐𝟒.𝟓% from India. The rhetoric just #DoesntAddUp
Sam Ricchezza retweeted
Halloween in the Village Saturday, Oct 26 from 11 to 2 pm. Bring your ghouls and Goblins by for a Halloween treat!
Capra's Kitchen had a pumpkin Carving Contest, please scroll thru our pumpkin Pictures and help us… instagram.com/p/B3u2bsthTfL/…
Sam Ricchezza retweeted
FDA issues draft guidance on DMFs (PDF): fda.gov/media/131861/downloa…
Sam Ricchezza retweeted
8 days until the 3rd annual @PBOAssoc Meeting & Conference: The only conference built for CMO/CDMOs! pharma-bio.org/conference
Sam Ricchezza retweeted
#Vaccine #investment breathing new life into space? biopharma-reporter.com/Artic… via @benhargreaves08 @BioPharmaReport. And this is a lot of what @BiologicsforAll is looking to address. Reduce cost, footprint and implementation to make vaccines accessible.
Sam Ricchezza retweeted
"Ontario's reputation as a world-leading centre of activity in #stemcell research is growing even stronger" via @clinicaltrialON bit.ly/2kJkaTf
Sam Ricchezza retweeted
LATimes - ‘It’s not working': An FDA insider’s view of where medical innovation falls short - by Emily Baumgaertner latimes.com/science/story/20…
Sam Ricchezza retweeted
We can't produce #celltherapy #genetherapy without #viralvectors & there is a global shortage. The newly funded iVexSol consortium, with CCRM @GE_LifeSciences @GEHealthcare @STEMCELLTech & funded by @NGen_Canada @ISED_CA will use an advanced tech to deliver these reagents
Sam Ricchezza retweeted
Don't miss these ISCT NA 2019 pre-meeting events! 1. ISCT 2019 Gene Therapy Signature Series 2. ISCT-FACT Cell Therapy Quality Bootcamp 3. FACT Accreditation Workshop bit.ly/2Mhrd1U
Sam Ricchezza retweeted
In a 1st, doctors in U.S. use CRISPR tool to treat patient with genetic disorder npr.org/sections/health-shot…
Sam Ricchezza retweeted
In a new SickKids-led @nature study, researchers used a modified version of #CRISPR gene-editing tool, potentially paving the way for entirely new treatment avenues for patients with a form of #musculardystrophy and other inherited diseases @Ronald_Cohn sickkids.ca/AboutSickKids/Ne…
Sam Ricchezza retweeted
Dr. Gary Pigeau is a crucial member of the @GEHealthcare team working @CCRM_ca. He joins Geoffry Hodge @unumrx in a webinar on designing production facilities of the future. Don't miss it. #webinar #manufacturing #GMP bit.ly/2JL1NHa
Sam Ricchezza retweeted
Day 2 of #PBOACon18 kicks off with some passionate talk from @BSI_EHS about EHS audits (no, seriously).
























